[{"_1":2,"_3":-5,"_4":-5},"loaderData",{"_5":6,"_7":8},"actionData","errors","root",{"_96":97},"routes/item",{"_9":10},"item",{"_11":12,"_13":14,"_15":16,"_17":18,"_19":20,"_21":-5,"_22":23,"_24":25,"_26":27,"_28":29,"_30":29,"_31":32,"_33":34,"_35":36,"_37":38,"_39":40,"_41":42,"_43":44,"_45":-5,"_46":47,"_48":-5,"_49":-5,"_50":51,"_52":53,"_54":55,"_56":57,"_58":57,"_59":60,"_61":40,"_62":63},"id","uh2kini5w0rdj8dt6z2z9x3ms","revision",3,"title","Aethlon Medical 修改公司章程以增加授权股本","originalTitle","AETHLON MEDICAL INC (0000882291) (Filer)","summary","Aethlon Medical 于 2026 年 10 月 7 日生效修改公司章程，将普通股授权股数从 2000 万股增至 2 亿股。此次修改于 2026 年 10 月 1 日经股东年会批准。","reason","source",{"_11":86,"_87":88,"_89":90,"_91":57,"_92":93,"_94":95},"links",{"_83":84,"_63":85},"publishedAt","2026-10-09T20:15:22.000Z","discoveredAt","2026-10-09T23:26:40.521Z","timelineAt","category","tip","tags",[81,82],"stockSymbols",[80],"score",12,"selected",false,"channel","news","story",{"_72":73,"_15":74},"x","readingMode","full","author","language","body",{"_76":-5,"_63":77,"_78":-5,"_79":40},"outline",[],"relatedStories",[75],"indexable",true,"markdownAvailable","group",{"_64":65,"_43":66,"_67":68,"_69":70,"_71":70},"hasTranslation","bodyLanguage","original","factId","fcwqB7k8Q3lk",{"_72":73,"_15":74},"reportCount",1,"additionalSourceCount",0,"developmentCount","publicId","cf7fe9f9-a36f-404b-9831-b3a8973fe50c","Aethlon Medical 股本调整与提案未通过",{"_72":73,"_15":74},"zh","

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities\nExchange Act of 1934

Date of Report (Date of earliest event reported):\nOctober 7, 2026

Aethlon\nMedical, Inc.

(Exact name of registrant as specified in its\ncharter)

\n \n \n \n \n \n \n \n \n \n \n \n \n

Nevada		001-37487		13-3632859
\n (State or other jurisdiction of\n incorporation)		\n (Commission File Number)		\n (IRS Employer Identification No.)

\n \n \n \n \n \n \n \n \n

11555\n Sorrento Valley Road, Suite\n 203

San Diego, California

92121

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including\narea code: (619) 941-0360

N/A

(Former name or former address, if changed since\nlast report)

Check the appropriate box below if the Form 8-K filing is intended\nto simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

\n \n \n \n

☒	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

\n \n \n \n

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

\n \n \n \n

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

\n \n \n \n

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

\n \n \n \n \n \n \n \n \n \n \n \n \n

Title of each class		\n Trading Symbol(s)		\n Name of each exchange on which registered
\n Common Stock, $0.001 par value per share		AEMD		The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth\ncompany as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange\nAct of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant\nhas elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant\nto Section 13(a) of the Exchange Act. ☐

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change\nin Fiscal Year.

As previously reported,\nat the 2026 Annual Meeting of Stockholders of Aethlon Medical, Inc. (the \"Company\") held on October 1, 2026, the Company's stockholders\napproved an amendment to the Company's Articles of Incorporation, as amended, to increase the number of authorized shares of the Company's\ncommon stock, par value $0.001 per share, from 20,000,000 shares to 200,000,000 shares (the \"Articles Amendment\").

The Articles Amendment\nwas filed with the Secretary of State of the State of Nevada and became effective on October 7, 2026, and amends Article V of the Company’s\nArticles of Incorporation to authorize an aggregate of 200,000,000 shares of common stock, par value $0.001 per share.

A copy of the Articles\nAmendment is filed herewith as Exhibit 3.1 and incorporated herein by reference. The foregoing summary of the Articles Amendment does\nnot purport to be complete and is qualified in its entirety by reference to such exhibit.

Item 9.01 Financial\nStatements and Exhibits.

(d) Exhibits

\n \n \n \n \n \n \n \n \n \n \n \n \n

Exhibit No.		Description
3.1		Certificate of Amendment to the Articles of Incorporation of Aethlon Medical, Inc., as filed with the Secretary of State of the State of Nevada on October 7, 2026
104		Cover Page Interactive Data File (embedded within the inline XBRL Document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the\nregistrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

Date: October 9, 2026	AETHLON MEDICAL, INC.

	By:	/s/ James B. Frakes
	\n Name: Title: \n	\n James B. Frakes \n Chief Executive Officer and Chief Financial Officer

","zhKind","complete","AEMD","政策与监管","公司与财报","aihot","/items/uh2kini5w0rdj8dt6z2z9x3ms","https://www.sec.gov/Archives/edgar/data/882291/000168316826007749/0001683168-26-007749-index.htm","rss-sec-xbrl","name","SEC · EDGAR 财务披露","kind","rss","firstParty","iconUrl","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar&exp=1791849600&sig=28e8ce8fbc2d0408","iconSrcSet","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-48&exp=1791849600&sig=ba56adc2357cc553 48w, /api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-96&exp=1791849600&sig=23c73794bac2d180 96w","changelogVersion","2026-10-01T08:00"]